A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)
Clinical trial NCT03395210 · COMPLETED
Trial details
- NCT number
- NCT03395210
- Sponsor
- Principia Biopharma, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2023-01-31
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.